tm logo
ANFYBI
Live/Registered
REGISTERED

on 09 Jul 2024

Last Applicant/ Owned by

65, quai Georges Gorse

Boulogne-Billancourt

FR

92100

Serial Number

97583720 filed on 08th Sep 2022

Registration Number

7436262 registered on 09th Jul 2024

in the Principal Register

Correspondent Address

Ben Natter

Ben Natter HAUG PARTNERS, LLP

NEW YORK, NY 10151

UNITED STATES

Filing Basis

No Filing Basis

Disclaimer

NO DATA

ANFYBI

Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, c Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified components of the toxin haemagglutin complex for skin care and the treatment of neurological disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97583720

Mark Type

No Service/Collective Mark

Attorney Docket Number

No A968-25

44D Filed

Yes

44D Current

Yes

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Jul 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
09th Jul 2024REGISTERED-PRINCIPAL REGISTER
23rd Apr 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23rd Apr 2024PUBLISHED FOR OPPOSITION
03rd Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21st Mar 2024APPROVED FOR PUB - PRINCIPAL REGISTER
13th Mar 2024TEAS/EMAIL CORRESPONDENCE ENTERED
13th Mar 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
12th Mar 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01st Mar 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED